Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Marked sarcoidosis-associated hypercalciuria in pregnancy is attributed to the increase in both renal and ectopic calcitriol production, due to pregnancy and sarcoid granulomas, respectively.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Narrative review.

Narrative review

Discusses existing research; systematic-review methods have not been established by this classification.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Gestational hypercalcemia: a narrative review of literature

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Gestational hypercalcemia: a narrative review of literature

Narrative review · Frontiers in Medicine · 2026

Original publication title

Gestational hypercalcemia: a narrative review of literature

Miriam Martin; Corin Heim; Martin Mueller; Markus Mohaupt

Copyright © 2026 Martin, Heim, Mueller and Mohaupt.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

More than 90% of cases of gestational hypercalcemia are caused by PHPT, which in turn is mostly caused (over 80%) by a single parathyroid adenoma. However, we have to consider a number of other possible etiologies. We need to consider the increased risk of maternal, neonatal, and fetal complications. The review illustrates the various clinical presentation and complex therapeutic management of gestational hypercalcemia, necessitating an interdisciplinary approach to the mother and child.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

We aim to perform a narrative literature review of gestational hypercalcemia including calcium homeostasis in pregnancy. Additionally, we demonstrate the diagnostic and therapeutic challenges and pitfalls of gestational hypercalcemia.

Source: Aim

Abstract: What methods does the paper describe?

Literature review.

Source: Methods

Abstract: Results

Gestational hypercalcemia is a rare yet life-threatening condition. The presentation of gestational hypercalcemia is nonspecific and mimics common pregnancy-related symptoms contributing to missed or late diagnosis. Common morbidities include nephrolithiasis and pancreatitis in the mother and adverse obstetrical outcomes such as fetal loss, fetal growth restriction, preeclampsia and preterm delivery. Severe cases of neonatal hypocalcemia due to fetal hypoparathyroidism may lead to tetany and even death. Despite these risks, only few guidelines in the management of gestational hypercalcemia exist. Causes of gestational hypercalcemia can be divided into parathyroid hormone (PTH)-dependent versus PTH-independent disorders.

PTH-dependent etiologies display increased or inappropriately high PTH levels; primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH) are the main contributors. PTH-independent disorders include pseudohyperparathyroidism, malignancy, and excessive calcium intake including calcium alkali syndrome. Granulomatous diseases, cytochrome P450 family 24 subfamily A member 1 (CYP24A1) mutations, and excessive calcium intake are the main contributors. In the presence of maternal hypercalcemia, hypercalciuria is a common laboratory finding. Extended laboratory work-up is the most useful paraclinical examination in gestational hypercalcemia of unknown cause.

Only FHH is usually associated with low urinary calcium excretion. Marked sarcoidosis-associated hypercalciuria in pregnancy is attributed to the increase in both renal and ectopic calcitriol production, due to pregnancy and sarcoid granulomas, respectively.

Source: Results

Abstract: Conclusion

More than 90% of cases of gestational hypercalcemia are caused by PHPT, which in turn is mostly caused (over 80%) by a single parathyroid adenoma. However, we have to consider a number of other possible etiologies. We need to consider the increased risk of maternal, neonatal, and fetal complications. The review illustrates the various clinical presentation and complex therapeutic management of gestational hypercalcemia, necessitating an interdisciplinary approach to the mother and child.

Source: Conclusion
Authors’ abstract

Aim

We aim to perform a narrative literature review of gestational hypercalcemia including calcium homeostasis in pregnancy. Additionally, we demonstrate the diagnostic and therapeutic challenges and pitfalls of gestational hypercalcemia.

Methods

Literature review.

Results

Gestational hypercalcemia is a rare yet life-threatening condition. The presentation of gestational hypercalcemia is nonspecific and mimics common pregnancy-related symptoms contributing to missed or late diagnosis. Common morbidities include nephrolithiasis and pancreatitis in the mother and adverse obstetrical outcomes such as fetal loss, fetal growth restriction, preeclampsia and preterm delivery. Severe cases of neonatal hypocalcemia due to fetal hypoparathyroidism may lead to tetany and even death. Despite these risks, only few guidelines in the management of gestational hypercalcemia exist. Causes of gestational hypercalcemia can be divided into parathyroid hormone (PTH)-dependent versus PTH-independent disorders.

PTH-dependent etiologies display increased or inappropriately high PTH levels; primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH) are the main contributors. PTH-independent disorders include pseudohyperparathyroidism, malignancy, and excessive calcium intake including calcium alkali syndrome. Granulomatous diseases, cytochrome P450 family 24 subfamily A member 1 (CYP24A1) mutations, and excessive calcium intake are the main contributors. In the presence of maternal hypercalcemia, hypercalciuria is a common laboratory finding. Extended laboratory work-up is the most useful paraclinical examination in gestational hypercalcemia of unknown cause.

Only FHH is usually associated with low urinary calcium excretion. Marked sarcoidosis-associated hypercalciuria in pregnancy is attributed to the increase in both renal and ectopic calcitriol production, due to pregnancy and sarcoid granulomas, respectively.

Conclusion

More than 90% of cases of gestational hypercalcemia are caused by PHPT, which in turn is mostly caused (over 80%) by a single parathyroid adenoma. However, we have to consider a number of other possible etiologies. We need to consider the increased risk of maternal, neonatal, and fetal complications. The review illustrates the various clinical presentation and complex therapeutic management of gestational hypercalcemia, necessitating an interdisciplinary approach to the mother and child.

Publication and source details

Original title: Gestational hypercalcemia: a narrative review of literature

Miriam Martin; Corin Heim; Martin Mueller; Markus Mohaupt

Frontiers in Medicine · 2026

* Correspondence: Martin Mueller, martin.mueller@unibe.ch
†

Both authors contributed equally

‡

Both authors contributed equally

Copyright © 2026 Martin, Heim, Mueller and Mohaupt.2026Martin, Heim, Mueller and Mohaupthttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:52:10.629869+00:00

DOI: 10.3389/fmed.2026.1909975 · PMC13548397